We are live on ! Find out more
IBRX icon

ImmunityBio
IBRX

60 hedge funds and large institutions have $57.4M invested in ImmunityBio in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 16 increasing their positions, 22 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

0.16% more ownership

Funds ownership: 19.55% → 19.72% (+0.16%)

12% less funds holding

Funds holding: 68 → 60 (-8)

27% less repeat investments, than reductions

Existing positions increased: 16 | Existing positions reduced: 22

33% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 9

38% less capital invested

Capital invested by funds: $92.1M → $57.4M (-$34.7M)

Holders
60
Holders Change
-8
Holders Change %
-11.76%
% of All Funds
1.49%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
6
Increased
16
Reduced
22
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$10.2M
2
Renaissance Technologies
Renaissance Technologies
New York
+$2.28M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$793K
4
Deutsche Bank
Deutsche Bank
Germany
+$681K
5
Barclays
Barclays
United Kingdom
+$411K

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.07M
2
Franklin Resources
Franklin Resources
California
-$631K
3
Millennium Management
Millennium Management
New York
-$525K
4
TI
Trexquant Investment
Connecticut
-$209K
5
Bank of America
Bank of America
North Carolina
-$186K
Name Holding Trade Value Shares
Change 		Change in
Stake
Manulife (Manufacturers Life Insurance)
51
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$8K -$16.8K -3,410 -60%
ClearBridge Investments
52
ClearBridge Investments
New York
$7K – – –
MAM
53
Meeder Asset Management
Ohio
$6K – – –
AIP
54
Ameritas Investment Partners
Nebraska
$5K +$6.45K +1,305 New
PNC Financial Services Group
55
PNC Financial Services Group
Pennsylvania
$2K – – –
BNP Paribas Financial Markets
56
BNP Paribas Financial Markets
France
$1.7K -$662 -134 -22%
CG
57
Cutler Group
California
$1K -$3.21K -650 -62%
Walleye Trading
58
Walleye Trading
New York
$209 +$292K +59,000 New
Franklin Resources
59
Franklin Resources
California
– -$631K -110,389 Closed
TI
60
Trexquant Investment
Connecticut
– -$209K -36,593 Closed
Citadel Advisors
61
Citadel Advisors
Florida
– -$106K -18,477 Closed
Tudor Investment Corp
62
Tudor Investment Corp
Connecticut
– -$102K -17,912 Closed
VKH
63
Virtu KCG Holdings
New York
– -$94K -16,369 Closed
OAC
64
OMERS Administration Corp
Ontario, Canada
– -$80K -13,900 Closed
TRCT
65
Tower Research Capital (TRC)
New York
– -$27K -4,593 Closed
NFG
66
Next Financial Group
Texas
– -$4K -725 Closed
1 2
3

IBRX Hedge Fund Activity: Q1 2017 in Review

60 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in ImmunityBio (IBRX) for Q1 2017, worth a combined $57.4M — down 38% from $92.1M a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of IBRX and 6 opened new positions — a net loss of 3 holders — while 22 trimmed existing stakes and 16 added.

The largest buyer was BlackRock, adding an estimated $10.2M. The largest seller was Fidelity Investments, cutting an estimated $2.07M.

  • 60 institutional investors held ImmunityBio (IBRX) as of Q1 2017, down from 68 in Q4 2016.
  • Funds reported $57.4M of ImmunityBio stock for Q1 2017, down 38% quarter-over-quarter.
  • 6 funds opened new ImmunityBio positions in Q1 2017 and 9 closed out, a net change of -3 holders.
  • The largest ImmunityBio buyer in Q1 2017 was BlackRock, an estimated $10.2M added.
  • The largest ImmunityBio seller in Q1 2017 was Fidelity Investments, an estimated $2.07M sold.

Based on aggregated 13F filings for Q1 2017.